MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab

E. Mensà; R. Recchioni; F. Marcheselli; K. Giuliodori; V. Consales; E. Molinelli; F. Prattichizzo; M. R. Rippo; A. Campanati; A. D. Procopio; F. Olivieri; A. M. Offidani

doi:10.1111/bjd.16659

MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab

E. Mensà, R. Recchioni, F. Marcheselli, K. Giuliodori, V. Consales, E. Molinelli, F. Prattichizzo, M. R. Rippo, A. Campanati, A. D. Procopio, F. Olivieri, A. M. Offidani

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	787-789
Number of pages	3
Journal	British Journal of Dermatology
Volume	179
Issue number	3
DOIs	https://doi.org/10.1111/bjd.16659
Publication status	Published - Sep 1 2018

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/bjd.16659

Cite this

Mensà, E., Recchioni, R., Marcheselli, F., Giuliodori, K., Consales, V., Molinelli, E., Prattichizzo, F., Rippo, M. R., Campanati, A., Procopio, A. D., Olivieri, F., & Offidani, A. M. (2018). MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab. British Journal of Dermatology, 179(3), 787-789. https://doi.org/10.1111/bjd.16659

MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab. / Mensà, E.; Recchioni, R.; Marcheselli, F.; Giuliodori, K.; Consales, V.; Molinelli, E.; Prattichizzo, F.; Rippo, M. R.; Campanati, A.; Procopio, A. D.; Olivieri, F.; Offidani, A. M.

In: British Journal of Dermatology, Vol. 179, No. 3, 01.09.2018, p. 787-789.

Research output: Contribution to journal › Letter › peer-review

Mensà, E, Recchioni, R , Marcheselli, F, Giuliodori, K, Consales, V, Molinelli, E, Prattichizzo, F, Rippo, MR, Campanati, A, Procopio, AD , Olivieri, F & Offidani, AM 2018, 'MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab', British Journal of Dermatology, vol. 179, no. 3, pp. 787-789. https://doi.org/10.1111/bjd.16659

Mensà, E. ; Recchioni, R. ; Marcheselli, F. ; Giuliodori, K. ; Consales, V. ; Molinelli, E. ; Prattichizzo, F. ; Rippo, M. R. ; Campanati, A. ; Procopio, A. D. ; Olivieri, F. ; Offidani, A. M. / MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab. In: British Journal of Dermatology. 2018 ; Vol. 179, No. 3. pp. 787-789.

@article{f663df3a61b140ce9d843a78306f11b1,

title = "MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab",

author = "E. Mens{\`a} and R. Recchioni and F. Marcheselli and K. Giuliodori and V. Consales and E. Molinelli and F. Prattichizzo and Rippo, {M. R.} and A. Campanati and Procopio, {A. D.} and F. Olivieri and Offidani, {A. M.}",

year = "2018",

month = sep,

day = "1",

doi = "10.1111/bjd.16659",

language = "English",

volume = "179",

pages = "787--789",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab

AU - Mensà, E.

AU - Recchioni, R.

AU - Marcheselli, F.

AU - Giuliodori, K.

AU - Consales, V.

AU - Molinelli, E.

AU - Prattichizzo, F.

AU - Rippo, M. R.

AU - Campanati, A.

AU - Procopio, A. D.

AU - Olivieri, F.

AU - Offidani, A. M.

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85052700855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052700855&partnerID=8YFLogxK

U2 - 10.1111/bjd.16659

DO - 10.1111/bjd.16659

M3 - Letter

AN - SCOPUS:85052700855

VL - 179

SP - 787

EP - 789

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 3

ER -

MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this